ProCE Banner Activity

CE / CME

Pharmacotherapy of Bipolar Depressive Spectrum Disorders

Multimedia
Listen to one of the world’s leading experts discuss the pharmacotherapy of bipolar depressive spectrum disorders.

Pharmacists : 1.50 contact {hours} ({0.15} CEUs)

Physicians : maximum of 1.50 AMA PRA Category 1 {Credits}

Physician Assistants : maximum of 1.50 {hours} of AAPA Category I (Preapproved) {credits}

Released: March 15, 2020

Expiration: March 15, 2021

No longer available for credit.

Share

Faculty

Prakash Masand

Prakash Masand, MD

Chief Medical Officer
Clinical Education Alliance
Adjunct Professor
Duke-NUS
New York, New York

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Neurocrine Biosciences

Sunovion

Takeda

Tris Pharmaceuticals

Partners

GME

ProCE Banner

Faculty Disclosure

Primary Author

Prakash Masand, MD

Chief Medical Officer
Clinical Education Alliance
Adjunct Professor
Duke-NUS
New York, New York

Consulting Fees: Allergan, Lundbeck, Sunovion, Takeda

Speakers Bureau: Allergan, Lundbeck, Sunovion, Takeda

Contracted Research: Allergan

Instructions for Credit

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 1.4 contact hours.

Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15CEUs) of the Accreditation Council for Pharmacy Education.

This activity is designated for 1.5 AAPA Category 1 CME Credit. PAs should only claim credit commensurate with the extent of their participation.

Additional Information

Program Medium

This program has been made available online.